CHKA and diffuse large B-cell lymphoma: Genetic silencing of CHKα or treatment with the CHKα inhibitor CK37 abrogates the apoptosis-inducing effects of the PI3K inhibitor AZD8186 in DLBCL cells, indicating a dependence of PI3K activation on CHKα up-regulation [83].